Acquired brain injury (ABI), Anxiety, Depression Niet aangeboren hersenletsel (NAH), Angst, Depressie
Conditions
Interventions
The participants receive Acceptance and Commitment Therapy or psycho-education combined with relaxation training. Both interventions consist of eight sessions which will last 60 till 90 minutes.
Sponsors
Maastricht University
Eligibility
Inclusion criteria
Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: - having sustained any type of stroke or traumatic brain injury which is objectified by a neurologist; - the depression subscale of the Hospital Anxiety and Depression Scale (HADS) is above 7 and/or the anxiety subscale of the HADS is above 7; - being 18 years or older; - stable use of medication (such as antidepressants) for the duration of the study and use of antidepressants should be stable four weeks prior to the beginning of the study; - access to the internet and a computer because treatment materials such as patient videos are shown via the internet; - the Dutch language, cognitive and communicative skills are sufficient to benefit from treatment based on clinical judgement; and - giving informed consent.
Exclusion criteria
Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: - history of brain injury or disease (objectified by neurologist and classified as moderate or severe) or any neurological disorder (such as: idiopathic epilepsy, brain tumor, meningioma, multiple sclerosis, Huntington’s disease, Parkinson’s disease, meningitis, or encephalitis) other than a stroke and traumatic brain injury; - pre-morbid disability as assessed with the Barthel Index (score<19/20); - severe co-morbidity that might affect outcome (e.g., cancer or major psychiatric illnesses for which treatment is given at the moment of inclusion); - ongoing mood and/or anxiety disorder based on the DSM 5 for which pharmacological and/or psychological treatment was necessary during the onset of the brain injury; - attendance in a previous ACT intervention for comparable problems in the year proceeding entry in the current study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome measure for clinical effectiveness is the Hospital Anxiety and Depression Scale (HADS) measuring depressive and anxiety symptoms. Primary outcome measure for the cost effectiveness will be the five-dimensional five-level EuroQol (EQ-5D-5L) and a cost-questionnaire specifically designed for this study. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcome measures are the Depression Anxiety Stress Scale (DASS-21), Utrecht Scale for Evaluation of Rehabilitation-Participation (USER-P), Short Form Survey (SF12), Acceptance and Action Questionnaire II (AAQ-II), Acceptance and Action Questionnaire after brain injury (AAQ-ABI), Valued Living Questionnaire (VLQ) and the Cognitive Fusion Questionnaire (CFQ-7). | — |
Contacts
Public ContactJohanne Rauwenhoff
Maastricht University
Outcome results
None listed